Journals / Turkish Journal of Gastroenterology / 2006 / Cilt: 17 - Sayı: 2

Üçüncül referans merkezinde Barrett özofagus ve eroziv özofajit sıklığı

The prevalence of Barrett's esophagus and erosive esophagitis in a tertiary referral center in Turkey

Pages
79–83
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Erosive esophagitis was diagnosed in 12.8% of overall patients by endoscopy and was significantly higher in patients with Barrett’s esophagus (27%, p=0.0001).

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/aims: In recent years, changes in the definition of Barrett’s esophagus have resulted in some difficulties in its diagnosis.
📊
Key Findings & Data:Very few epidemiological data on Barrett’s esophagus and erosive esophagitis in Turkey are available in the literature.
💡
Conclusion & Impact:Erosive esophagitis was diagnosed in 12.8% of overall patients by endoscopy and was significantly higher in patients with Barrett’s esophagus (27%, p=0.0001).
🔬Design:Research Article
📍Scope:2001 Verileri
⚙️Variables:Fıtık · hiatal · Geriyedönük çalışma

Abstract

Background/aims: In recent years, changes in the definition of Barrett&#8217;s esophagus have resulted in some difficulties in its diagnosis. Very few epidemiological data on Barrett&#8217;s esophagus and erosive esophagitis in Turkey are available in the literature. The aim of this study was to determine the prevalence of Barrett&#8217;s esophagus and erosive esophagitis in a tertiary referral center in Turkey. Methods: 18,766 endoscopic examinations done in Ege University between October 1996 and June 2001 were included in this retrospective study. The histologic identification of goblet cells confirming the presence of intestinal metaplasia within the esophagus was considered as Barrett&#8217;s esophagus. Results: 280/18,766 (1.5%) cases were suspected as Barrett&#8217;s esophagus by endoscopy. 84/18,766 (0.4%) cases were confirmed pathologically. Thirty-six cases were women and 48 men; mean age was 55.6 years. Pathology did not confirm the diagnosis in 46% of the long-segment Barrett&#8217;s esophagus and in 72% of the short-segment Barrett&#8217;s esophagus cases (p<0.01). Erosive esophagitis was diagnosed in 12.8% of overall patients by endoscopy and was significantly higher in patients with Barrett&#8217;s esophagus (27%, p=0.0001). Hiatal hernia was found in 5% of Barrett&#8217;s esophagus cases and in 11.2% of the endoscopically suspected Barrett&#8217;s esophagus cases (p>0.05). Conclusion: The prevalence of Barrett&#8217;s esophagus and erosive esophagitis are much lower than in developed countries. In the endoscopic examination, overdiagnosis of Barrett&#8217;s esophagus is still a problem, especially in the presence of short-segment Barrett&#8217;s esophagus. The presence of hiatal hernia did not affect the diagnosis.

Özet

Amaç: Son yıllarda Barrett özofagus tanımlamasındaki değişiklik Barrett özofagus tanısını koymada bazı zorlukları da beraberinde getirmiştir. Literatürde Türkiye'deki Barrett özofagus ve eroziv özofajit sıklığı ili ilgili epidemiyolojik veri azdir. Çalışmada Türkiye'de üçüncül bir referans merkezdeki Barrett özofagus ve eroziv özofajit sıklığının belirlenmesi amaçlanmıştır. Yöntem: Bu retrospektif çalışmaya 1996-Haziran 2001 yılları arasında Ege Universitesi'nde yapılan 18766 endoskopik inceleme dahil edilmiştir. Özofagusda goblet hücrelerinin intestinal metaplazi varlığında histolojik olarak tanınması Barrett özofagus olarak adlandırılmıştır. Bulgular: 280/18766 (%1.5) vakada endoskopik olarak Barrett özofagus düşünülmüştür. 84/18766 (%0.4) vaka histopatolojik olarak doğrulanmıştır. Vakaların 36'sı kadın, 48'i erkek, yaş ortalaması 55,6'dır. Kısa segment Barrett özofagus olgularının %72'si, uzun segment Barrett özofagus olgularının ise %46` nın tanısı patoloji tarafı ndan doğrulanmamıştır (p 0.05). Sonuç: Barrett özofagus ve eroziv özofajit sıklığı gelişmiş ülkelerden daha azdır. Endoskopik incelemede özellikle kısa segment özofagus varlığında fazla Barrett özofagus tanısı hala sorundur. Hiatus herni varlığı tanıyı etkilememektedir.

🔖

Cite This Article

YILMAZ, N., TUNCER, K., TUNÇYÜREK, M., ÖZÜTEMİZ, Ö., BOR, S. (2006). Üçüncül referans merkezinde Barrett özofagus ve eroziv özofajit sıklığı. Turkish Journal of Gastroenterology, Cilt: 17 - Sayı: 2, 79–83. https://ajindex.com/articles/409992

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Fass R, Ofman JJ. Gastroesophageal reflux disease. Should we adopt a new conceptual framework? Am J Gastroenterol 2002; 97: 1901-9
  2. Şenturk O, Aydin S, Sengul E, et al. Is the rate of esophagitis changing? (Özofajitin görülme sıklığı değişiyor mu?). Turk J Gastroenterol 2000; 11 (Suppl 1): Abstract -160
  3. Tunc B, Saritas U, Altintas E, et al. The clinical, endoscopic and histologic properties of Barrett’s esophagus cases (Barret ozofagus olgularinin kilinik, endoskopik ve histolojik özellikleri). Turk J Gastroenterol 2000; 11 (Suppl 1): Abstract -165
  4. Haggitt RC. Barrett’s esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994; 25: 982-93
  5. Sampliner RE, and the Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 1998; 93: 1028-32
  6. Conio M, Lapertosa G, Blanchi S, Filiberti R. Barrett's esophagus: An update. Crit Rev Oncol Hematol 2003; 46: 187-206
  7. Peters JH, Hagen JA, DeMeester SR. Barrett's esophagus. J Gastrointest Surg 2004; 8: 1-17
  8. Rudolph, RE, Vaughan TL, Storer BE, et al. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med 2000; 132: 612-20
  9. Shaheen NJ. Advances in Barrett's esophagus and esophageal adenocarcinoma. Gastroenterology 2005; 128: 1554-66
  10. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000; 119: 333-8
  11. Csendes A, Smok G, Burdiles P, et al. Prevalence of Barrett's esophagus by endoscopy and histologic studies: A prospective evaluation of 306 control subjects and 376 patients with symptoms of gastroesophageal reflux. Dis Esophagus 2000; 13: 5-11
  12. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett’s esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-7
  13. Bor S, Mandiracioglu A, Kitapcioglu G, et al. Gastroesophageal reflux disease in a low income region in Turkey. Am J Gastroenterol 2005; 100: 759-65
  14. Toruner M, Soykan I, Ensari A, et al. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms. J Gastroenterol Hepatol 2004; 19: 535-40
  15. Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9
  16. Hansson LE, Sparen P, Nyren O. Increasing incidence of carcinoma of the gastric c